Moncef Slaoui, who led Operation Warp Speed under the Trump administration, has been fired as the chairman of a private company’s board of directors following an investigation into a claim of sexual harassment.
GlaxoSmithKline, which is the majority shareholder of Galvani Bioelectronics, announced Slaoui’s termination, effective immediately, on Wednesday. An investigation substantiated an allegation of sexual harassment and inappropriate conduct by Slaoui toward an employee, the company said.
Recommended Stories
FORMER OPERATION WARP SPEED BOSS SAYS ‘90%’ OF BIDEN VACCINE PLAN CAME FROM TRUMP ADMINISTRATION
The board initiated the investigation after receiving the complaint, which came in the form of a letter. The alleged inappropriate conduct took place “several years ago when he was an employee.”
“Dr. Slaoui’s behaviours are wholly unacceptable,” the company said. “They represent an abuse of his leadership position, violate company policies, and are contrary to the strong values that define GSK’s culture. The company expects everyone at GSK to behave in accordance with its values, especially its leaders where its standards are the highest. Sexual harassment and any abuse of leadership position are strictly prohibited and will not be tolerated.”
CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER
Christopher Corsico, senior vice president of development at GlaxoSmithKline, was appointed as Slaoui’s replacement. He was a member of the board before the promotion.
Slaoui did not remain with the administration after President Biden’s inauguration.
